Prophylaxis against early adrenal insufficiency to prevent chronic lung disease in premature infants

Pediatrics

Volumn 104, Issue 6, 1999, Pages 1258-1263

  Watterberg, Kristi L ^a,c   Gerdes, Jeffrey S ^b   Gifford, Kathleen L ^a   Lin, Hung Mo ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

Adrenal function; Bronchopulmonary dysplasia; Chorioamnionitis; Chronic lung disease; Hydrocortisone; Premature infant

Indexed keywords

HYDROCORTISONE SODIUM SUCCINATE; PLACEBO; TETRACOSACTIDE;

ADRENAL INSUFFICIENCY; ARTICLE; CHORIOAMNIONITIS; CHRONIC LUNG DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; INFANT; INTRAVENOUS DRUG ADMINISTRATION; LOW BIRTH WEIGHT; MALE; PREMATURITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SURVIVAL TIME; WEIGHT GAIN;

EID: 0032714191     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.104.6.1258     Document Type: Article

References (47)

1. Gross SJ, Iannuzzi DM, Kveselis DA, Anbar RD. Effect of preterm birth on pulmonary function at school age: a prospective controlled study. J Pediatr. 1998;133:188-192
2. Jacob SV, Coates AL, Lands LC, et al. Long-term pulmonary sequelae of severe bronchopulmonary dysplasia. J Pediatr. 1998;133:193-200
3. Gregoire MC, Lefebvre F, Glorieux J. Health and developmental outcomes at 18 months in very preterm infants with bronchopulmonary dysplasia. Pediatrics. 1998;101:856-860
4. Barrington KJ, Finer NN. Treatment of bronchopulmonary dysplasia. Clin Perinatol. 1998;25:177-202
5. Brozanski BS, Jones JG, Gilmour CH, et al. Effect of pulse dexamethasone therapy on the incidence and severity of chronic lung disease in the very low birth weight infant. J Pediatr. 1995;126:769-776
6. Rastogi A, Akintorin SM, Bez ML, Morales P, Pildes RS. A controlled trial of dexamethasone to prevent bronchopulmonary dysplasia in surfactant-treated infants. Pediatrics. 1996;98:204-210
7. Yeh TF, Lin YJ, Hseih WS, et al. Early postnatal dexamethasone therapy for the prevention of chronic lung disease in preterm infants with respiratory distress syndrome: a multicenter clinical trial. Pediatrics. 1997;100(4). URL: http://www.pediatrics.org/cgi/content/full/100/ 4/e3
8. Tapia JL, Ramirez R, Cifuentes J, et al. The effect of early dexamethasone administration on bronchopulmonary dysplasia in preterm infants with respiratory distress syndrome. J Pediatr. 1998;132:48-52
9. Bancalari E. Corticosteroids and neonatal chronic lung disease. Eur J Pediatr. 1998;157:31-37. Supplement
10. Yeh TF, Lin YJ, Huang CC, et al. Early dexamethasone therapy in preterm infants: a follow-up study. Pediatrics. 1998;101(5). URL: http:// www.pediatrics.org/cgi/content/full/101/5/e7
11. O'Shea TM, Kothadia JM, Klinepeter KL, et al. Effect of a 42-day tapering course of dexamethasone on outcome at one year of age in very preterm infants. Pediatrics. 1999;104:18-21
12. Pierce MR, Bancalari E. The role of inflammation in the pathogenesis of bronchopulmonary dysplasia. Pediatr Pulmonol. 1995;19:371-378
13. Warner BB, Stuart LA, Papes RA, Wispe JR. Functional and pathological effects of prolonged hyperoxia in neonatal mice. Am J Physiol 1998;275: L110-L117
14. Dreyfuss D, Saumon G. Ventilator-induced lung injury. Am J Respir Crit Care Med. 1998;157:294-323
15. Fujimura M, Takeuchi T, Kitajima H, Nakayama M. Chorioamnionitis and serum IgM in Wilson-Mikity syndrome. Arch Dis Child. 1989;64: 1379-1383
16. Yoon BH, Romero R, Jun JK, et al. Amniotic fluid cytokines (interleukin-6, tumor necrosis factor-α, interleukin-1β, and interleukin-8) and the risk for the development of bronchopulmonary dysplasia. Am J Obstet Gynecol. 1997;117:825-830
17. Watterberg KL, Demers LM, Scott SM, Murphy S. Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonary dysplasia develops. Pediatrics. 1996;97:210-215
18. Cordero L, Ayers LW, Davis K. Neonatal airway colonization with gram-negative bacilli: association with severity of bronchopulmonary dysplasia. Pediatr Infect Dis J. 1997;16:18-23
19. Colasurdo MA, Hanna CE, Gilhooly JT, Reynolds JW. Hydrocortisone replacement in extremely premature infants with cortisol insufficiency. Clin Res. 1989;37:180A
20. Ward RM, Kimura RE, Rich-Denson C. Addisonian crisis in extremely premature neonates. Clin Res. 1991;39:11A
21. Lee MM, Rajagopalan L, Berg GJ, Moshang T. Serum adrenal steroid concentrations in premature infants. J Clin Endocrinol Metab. 1989;69: 1133-1136
22. Hingre RV, Gross SJ, Hingre KS, Mayes DM, Richman RA. Adrenal steroidogenesis in very low birth weight preterm infants. J Clin Endocrinol Metab. 1994;78:266-270
23. Hanna CE, Jett PL, Laird MR, Mandel SH, LaFranchi SH, Reynolds JW. Corticosteroid binding globulin, total serum cortisol, and stress in extremely low-birth-weight infants. Am J Perinatol. 1997;14:201-204
24. Korte C, Styne D, Merritt TA, Mayes D, Wertz A, Helbock HJ. Adrenocortical function in the very low birth weight infant: improved testing sensitivity and association with neonatal outcome. J Pediatr. 1996;128: 257-263
25. Scott SM, Watterberg KL. Effect of gestational age, postnatal age, and illness on plasma cortisol concentrations in premature infants. Pediatr Res. 1995;37:112-116
26. Watterberg KL, Scott SM. Evidence of early adrenal insufficiency in babies who develop bronchopulmonary dysplasia. Pediatrics. 1995;95: 120-125
27. Haycock GB, Chir B, Schwartz GJ, Wisotsky DH. Geometric method for measuring body surface area: a height-weight formula validated in infants, children and adults. J Pediatr. 1978;93:62-66
28. Watterberg KL, Cook K, Gifford KL. Pharmacokinetics of hydrocortisone (HC) in extremely low birthweight (ELBW) infants in the first week of life. Pediatr Res. 1996;39:251A
29. Metzger DL, Wright NM, Veldhuis JD, Rogol AD, Kerrigan JR. Characterization of pulsatile secretion and clearance of plasma cortisol in premature and term neonates using deconvolution analysis. J Clin Endocrinol Metab. 1993;77:458-463
30. Watterberg KL, Scott SM, Naeye RL. Chorioamnionitis, cortisol, and acute lung disease in very low birth weight infants. Pediatrics. 1997; 99(2). URL:http://www.pediatrics.org/cgi/content/full/99/2/e6
31. Vermont Oxford Network. Vermont Oxford Network Annual Database Summary, 1997. Burlington, VT: Vermont Oxford Network; 1998
32. Scott SM, Watterberg K, Rogers C, Hartenberger C, Merker L, Gifford KL. Positive relationship of cortisol concentrations and oral nutrition to epidermal growth factor concentrations in preterm infants. Biol Neonate. 1998;74:259-265
33. Trahair JF, Sangild PT. Systemic and luminal influences on the perinatal development of the gut. Equine Vet J. 1997;24:40-50. Supplement
34. Nanthakumar NN, Henning SJ. Distinguishing normal and glucocorticoid-induced maturation of intestine using bromodeoxyuridine. Am J Physiol. 1995;268:G139-G145
35. Hillier SL, Krohn MA, Kiviat NB, Watts DH, Eschenbach DA. Microbiologic causes and neonatal outcomes associated with chorioamnion infection. Am J Obstet Gynecol. 1991;165:955-961
36. Kitajima H, Nakayama M, Miyano A, et al. Significance of chorioamnionitis. Early Hum Dev. 1992;29:125-130
37. Botas CM, Kurlat I, Young SM, Sola A. Disseminated candidal infections and intravenous hydrocortisone in preterm infants. Pediatrics. 1995;95:883-887
38. Merz U, Pfäffle R, Peschgens T, Hörnchen H. The hypothalamicpituitary-adrenal axis in preterm infants weighing ≤ 1250 g: association with perinatal data and chronic lung disease. Acta Paediatr. 1998;87: 313-317
39. Goujon E, Parnet P, Laye S, Combe C, Dantzer R. Adrenalectomy enhances pro-inflammatory cytokines gene expression, in the spleen, pituitary and brain of mice in response to lipopolysaccharide. Brain Res Mol Brain Res. 1996;36:53-62
40. Farsky SP, Sannomiya P, Garcia-Leme J. Secreted glucocorticoids regulate leukocyte-endothelial interactions in inflammation: a direct vital microscopic study. J Leukoc Biol. 1995;57:379-386
41. Chrousos GP. The hypothalamic-pituitary adrenal axis and immune-mediated inflammation. N Engl J Med. 1995;332:1351-1362
42. Helbock HJ, Insoft RM, Conte FA. Glucocorticoid-responsive hypotension in extremely low birth weight newborns. Pediatrics. 1993;92:715-717
43. Bourchier D, Weston PJ. Randomised trial of dopamine compared with hydrocortisone for the treatment of hypotensive very low birthweight infants. Arch Dis Child. 1997;76:F174-F178
44. Morales P, Rastogi A, Bez ML, et al. Effect of dexamethasone therapy on the neonatal ductus arteriosus. Pediatr Cardiol. 1998;19:225-229
45. +-ATPase mRNA in the developing lung and kidney. Pediatr Res. 1993;33:5-9
46. Kimura T, Ota K, Shoji M, et al. Plasma vasopressin and atrial natriuretic hormone levels in hypopituitarism with and without hydrocortisone treatments: responses to an acute water load. Acta Endocrinol. 1992;126:217-223
47. Papile L-A, Tyson JE, Stoll BJ, et al. A multicenter trial of two dexamethasone regimens in ventilator-dependent premature infants. N Engl J Med. 1998;338:1112-1118